BTX

Brooklyn ImmunoTherapeut... News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Brooklyn ImmunoTherapeutics Inc BTX AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.32 -3.19% 9.72 20:00:00
Open Price Low Price High Price Close Price Prev Close
9.88 9.41 10.1182 9.48 10.04
more quote information »

Recent News

Date Time Source Heading
9/24/20219:15IHNWFeaturedINTEGRATED VENTURES REPORTS 2021 REVENUES OF $1,851,390 AND SHAREHOLDER'S EQUITY OF $13,363,965.
9/23/202116:31EDGARCurrent Report Filing (8-k)
9/23/202116:30GLOBEBrooklyn ImmunoTherapeutics Reports Inducement Grants
9/22/202116:57EDGARStatement of Changes in Beneficial Ownership (4)
9/22/202110:07GLOBEBrooklyn ImmunoTherapeutics Appoints Roger Sidhu, M.D. as..
9/21/202108:30GLOBEBrooklyn ImmunoTherapeutics Provides Highlights of..
9/15/202108:15PRNUSFactor Bioscience Celebrates 10th Anniversary with Grand..
9/14/202107:01EDGARCurrent Report Filing (8-k)
9/13/202108:00GLOBEBrooklyn ImmunoTherapeutics to Conduct Shareholder Update..
9/09/202108:30GLOBEBrooklyn ImmunoTherapeutics to Participate in Grand Opening..
8/27/202117:46EDGARStatement of Ownership (sc 13g)
8/20/202116:46EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/20/202116:46EDGARCurrent Report Filing (8-k)
8/20/202116:15GLOBEBrooklyn ImmunoTherapeutics Announces Adjournment of Annual..
8/20/202113:40EDGARStatement of Changes in Beneficial Ownership (4)
8/20/202108:30GLOBEBrooklyn ImmunoTherapeutics Provides Highlights of..
8/17/202117:29EDGARCurrent Report Filing (8-k)
8/16/202116:15GLOBEBrooklyn ImmunoTherapeutics to Conduct Shareholder Update..
8/16/202107:00GLOBEBrooklyn ImmunoTherapeutics Announces Second Quarter 2021..
8/13/202117:06EDGARSecurities Registration Statement (simplified Form) (s-3)
8/13/202114:21GLOBEBrooklyn ImmunoTherapeutics to Present at the SNN Virtual..
7/26/202116:06EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/23/202116:30GLOBEBrooklyn Immuno Reports Inducement Grants
7/19/202116:06EDGARCurrent Report Filing (8-k)
7/19/202110:22SEEKBrooklyn ImmunoTherapeutics completes acquisition of..
7/19/202108:00GLOBEBrooklyn ImmunoTherapeutics Completes Acquisition of..
7/13/202108:15GLOBEBrooklyn ImmunoTherapeutics Welcomes Jay Sial as Chief..
7/12/202108:15GLOBEBrooklyn ImmunoTherapeutics to Present at the Access to..
7/06/202117:56GLOBEBrooklyn ImmunoTherapeutics Reports Inducement Grants
6/22/202118:01EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202118:00EDGARInitial Statement of Beneficial Ownership (3)
6/21/202117:01EDGARProxy Statement - Notice of Shareholders Meeting..
6/21/202117:01EDGARCurrent Report Filing (8-k)
6/14/202117:01EDGARCurrent Report Filing (8-k)
6/14/202107:50SEEKBrooklyn Immunotherapeutics shares surge on $125M Novellus..
6/14/202107:30GLOBEBrooklyn ImmunoTherapeutics Executes Letter of Intent to..
6/10/202117:21EDGARCurrent Report Filing (8-k)
6/07/202106:02EDGARNotice of Effectiveness (effect)
6/04/202112:21EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
6/03/202117:22EDGARSecurities Registration: Employee Benefit Plan (s-8)
5/26/202117:20EDGARCurrent Report Filing (8-k)
5/26/202114:03BWBrooklyn ImmunoTherapeutics CEO Howard J. Federoff Provides..
5/26/202110:06EDGARAmended Statement of Ownership (sc 13g/a)
5/25/202117:16SEEKBrooklyn Therapeutics sees mRNA license as key to future,..
5/25/202115:25SEEKBrooklyn ImmunoTherapeutics slips ahead of corporate update
5/24/202115:31SEEKBrooklyn ImmunoTherapeutics completes $20 million financing
5/24/202114:58BWBrooklyn ImmunoTherapeutics Strengthens Investment in..
5/24/202113:04EDGARStatement of Ownership (sc 13g)
5/21/202107:41SEEKBrooklyn ImmunoTherapeutics adds Michael Andreeff to..
5/21/202107:30BWMichael Andreeff, M.D., Ph.D to Join the Scientific Advisory..
5/19/202110:42EDGARInitial Statement of Beneficial Ownership (3)
See more news about this stock »


Your Recent History
AMEX
BTX
Brooklyn I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.